Glycated Fibrinogen: a New Index of Short-term Diabetic Control
Overview
Affiliations
Fibrinogen is a plasma protein with a short half-life of four days and, therefore, glycated fibrinogen may be valuable as an index of short-term diabetic control. We have developed a simple, rapid method for determining glycated fibrinogen using affinity chromatography. The differences in the percentage of glycated fibrinogen between normal subjects, well-controlled diabetics and poorly-controlled diabetics were highly significant. There was a significant correlation between glycated fibrinogen and glycated haemoglobin for all these subjects. However, in selected subjects with rapidly improving diabetic control the difference between the fall over three days in glycated fibrinogen and glycated haemoglobin was highly significant. In subjects with deteriorating control over an average of four weeks there was a significant difference between the increase in glycated fibrinogen and glycated haemoglobin. We suggest that glycated fibrinogen may be a valuable adjunct to glucose measurements in the assessment of short-term diabetic control due to its rapid change following alterations in control.
Tenopoulou M FEBS J. 2024; 292(1):11-27.
PMID: 39180244 PMC: 11705221. DOI: 10.1111/febs.17236.
Yamamoto K, Ito T, Nagasato T, Shinnakasu A, Kurano M, Arimura A Thromb J. 2019; 17:17.
PMID: 31496922 PMC: 6717975. DOI: 10.1186/s12959-019-0206-8.
Darling A, Uversky V Front Genet. 2018; 9:158.
PMID: 29780404 PMC: 5945825. DOI: 10.3389/fgene.2018.00158.
Lee S, Hong J, Lee S, Kang D, Ovbiagele B, Demchuk A BMC Neurol. 2017; 17(1):101.
PMID: 28525972 PMC: 5438529. DOI: 10.1186/s12883-017-0865-7.
Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.
Kearney K, Tomlinson D, Smith K, Ajjan R Cardiovasc Diabetol. 2017; 16(1):34.
PMID: 28279217 PMC: 5345237. DOI: 10.1186/s12933-017-0515-9.